{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["6-Hydroxydopamine", "Alpha lipoamide", "Mitochondrial dynamics", "Parkinson\u2019s disease"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29019159", "DateCompleted": {"Year": "2018", "Month": "12", "Day": "11"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "10", "Day": "10"}], "Language": ["eng"], "ELocationID": ["10.1007/s12640-017-9819-5"], "Journal": {"ISSN": "1476-3524", "JournalIssue": {"Volume": "33", "Issue": "4", "PubDate": {"Year": "2018", "Month": "May"}}, "Title": "Neurotoxicity research", "ISOAbbreviation": "Neurotox Res"}, "ArticleTitle": "Alpha Lipoamide Ameliorates Motor Deficits and Mitochondrial Dynamics in the Parkinson's Disease Model Induced by 6-Hydroxydopamine.", "Pagination": {"StartPage": "759", "EndPage": "767", "MedlinePgn": "759-767"}, "Abstract": {"AbstractText": ["The precise mechanisms underlying neuronal injury in Parkinson's disease (PD) are not yet fully elucidated; however, evidence from the in vitro and in vivo PD models suggest that mitochondrial dysfunction may play a major role in PD pathogenesis. Alpha lipoamide, a neutral amide derivative of the lipoic acid, is a better cofactor for mitochondrial dehydrogenase with a stronger protective effect on mitochondria than lipoic acid. Identification of these protective effects of alpha lipoamide on mitochondria, together with the evidence that mitochondrial dysfunction plays a critical role in PD, we speculate that alpha lipoamide may exert a protective effect in PD by regulating the mitochondrial function. The present study investigated the neuroprotective effects of alpha lipoamide in an animal model of PD induced by 6-hydroxydopamine (6-OHDA). The results demonstrated that alpha lipoamide could significantly antagonize the 6-OHDA-induced behavioral damages; restore ATP levels in the midbrain; and also improve the fragmentation, vacuolization, and morphology of the mitochondria. The results of Western blot indicated that alpha lipoamide significantly restored the number of dopaminergic neurons in midbrain and substantially recovered the balance between mitochondrial fission, fusion, and transport. In conclusion, the results demonstrated that alpha lipoamide might exert a significant neuroprotective effect in the animal model of PD by regulation of the dynamic properties of mitochondria."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guizhou, 550004, China."}, {"Identifier": [], "Affiliation": "Engineering Technology Research Center for Chemical Drug R&D, Guizhou, 550004, China."}, {"Identifier": [], "Affiliation": "College of Basic Medical, Guizhou Medical University, Guizhou, 550004, China."}], "LastName": "Zhou", "ForeName": "Bo", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical, Guizhou Medical University, Guizhou, 550004, China."}], "LastName": "Wen", "ForeName": "Min", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical, Guizhou Medical University, Guizhou, 550004, China."}], "LastName": "Lin", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical, Guizhou Medical University, Guizhou, 550004, China."}], "LastName": "Chen", "ForeName": "Yun-Hua", "Initials": "YH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical, Guizhou Medical University, Guizhou, 550004, China."}], "LastName": "Gou", "ForeName": "Yun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guizhou, 550004, China."}, {"Identifier": [], "Affiliation": "Engineering Technology Research Center for Chemical Drug R&D, Guizhou, 550004, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guizhou, 550004, China."}], "LastName": "Li", "ForeName": "Yong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guizhou, 550004, China."}, {"Identifier": [], "Affiliation": "Engineering Technology Research Center for Chemical Drug R&D, Guizhou, 550004, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guizhou, 550004, China."}], "LastName": "Zhang", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical, Guizhou Medical University, Guizhou, 550004, China."}], "LastName": "Li", "ForeName": "Hong-Wei", "Initials": "HW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guizhou, 550004, China. tlei1974@hotmail.com."}, {"Identifier": [], "Affiliation": "Engineering Technology Research Center for Chemical Drug R&D, Guizhou, 550004, China. tlei1974@hotmail.com."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guizhou, 550004, China. tlei1974@hotmail.com."}], "LastName": "Tang", "ForeName": "Lei", "Initials": "L"}], "GrantList": [{"GrantID": "LH[2014]7077", "Agency": "Natural Science Foundation of Guizhou Province of China", "Country": "International"}, {"GrantID": "[2016]5402", "Agency": "The engineering and technology research center for development and utilization of Chemical synthetic drug in Guizhou Province of China", "Country": "International"}, {"GrantID": "KY[2014]219", "Agency": "The engineering research center for pharmaceutical chemistry in regular institution of higher education of Guizhou Province of China", "Country": "International"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Neurotox Res", "NlmUniqueID": "100929017", "ISSNLinking": "1029-8428"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Dopamine Agonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Mitochondrial Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Sympatholytics"}, {"RegistryNumber": "73Y7P0K73Y", "NameOfSubstance": "Thioctic Acid"}, {"RegistryNumber": "8HW4YBZ748", "NameOfSubstance": "Oxidopamine"}, {"RegistryNumber": "8L70Q75FXE", "NameOfSubstance": "Adenosine Triphosphate"}, {"RegistryNumber": "N21FAR7B4S", "NameOfSubstance": "Apomorphine"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Adenosine Triphosphate"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Apomorphine"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Death"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Dopamine Agonists"}, {"QualifierName": ["drug effects"], "DescriptorName": "Dopaminergic Neurons"}, {"QualifierName": ["drug effects"], "DescriptorName": "Exploratory Behavior"}, {"QualifierName": ["physiopathology"], "DescriptorName": "Forelimb"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Mesencephalon"}, {"QualifierName": [], "DescriptorName": "Microscopy, Electron, Transmission"}, {"QualifierName": ["drug effects", "pathology", "ultrastructure"], "DescriptorName": "Mitochondria"}, {"QualifierName": ["drug effects"], "DescriptorName": "Mitochondrial Dynamics"}, {"QualifierName": ["metabolism"], "DescriptorName": "Mitochondrial Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Motor Activity"}, {"QualifierName": ["drug therapy", "etiology", "pathology"], "DescriptorName": "Motor Disorders"}, {"QualifierName": ["toxicity"], "DescriptorName": "Oxidopamine"}, {"QualifierName": ["complications", "drug therapy", "etiology"], "DescriptorName": "Parkinson Disease"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["toxicity"], "DescriptorName": "Sympatholytics"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Thioctic Acid"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Int J Mol Med. 2013 Jul;32(1):108-14", "ArticleIdList": ["23615851"]}, {"Citation": "Brain Res. 2013 Apr 10;1505:68-74", "ArticleIdList": ["23415934"]}, {"Citation": "Neurobiol Dis. 2013 Mar;51:43-55", "ArticleIdList": ["22668779"]}, {"Citation": "Free Radic Biol Med. 2008 Apr 1;44(7):1465-74", "ArticleIdList": ["18258206"]}, {"Citation": "Lancet. 2015 Aug 29;386(9996):896-912", "ArticleIdList": ["25904081"]}, {"Citation": "Neurobiol Dis. 2016 Nov;95:238-49", "ArticleIdList": ["27452482"]}, {"Citation": "Annu Rev Pathol. 2011;6:193-222", "ArticleIdList": ["21034221"]}, {"Citation": "Transl Neurodegener. 2016 Oct 31;5:19", "ArticleIdList": ["27822367"]}, {"Citation": "Pharmacol Ther. 2011 Jun;130(3):348-63", "ArticleIdList": ["21420428"]}, {"Citation": "Mol Cell Neurosci. 2013 Jul;55:101-14", "ArticleIdList": ["23220289"]}, {"Citation": "PLoS One. 2015 Jun 01;10(6):e0128502", "ArticleIdList": ["26030919"]}, {"Citation": "Neuron. 2015 Jul 15;87(2):371-81", "ArticleIdList": ["26182419"]}, {"Citation": "J Vis Exp. 2012 Feb 14;(60):null", "ArticleIdList": ["22370630"]}, {"Citation": "Biochem Soc Trans. 2016 Dec 15;44(6):1725-1735", "ArticleIdList": ["27913683"]}, {"Citation": "Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11364-9", "ArticleIdList": ["18687901"]}, {"Citation": "Annu Rev Genet. 2012;46:265-87", "ArticleIdList": ["22934639"]}, {"Citation": "Oxid Med Cell Longev. 2015;2015:408927", "ArticleIdList": ["26064418"]}, {"Citation": "Cold Spring Harb Perspect Biol. 2013 Jun 01;5(6):null", "ArticleIdList": ["23732472"]}, {"Citation": "Exp Cell Res. 2015 May 15;334(1):35-44", "ArticleIdList": ["25612908"]}, {"Citation": "Front Genet. 2015 Mar 11;6:78", "ArticleIdList": ["25815004"]}, {"Citation": "CNS Neurosci Ther. 2017 Jan;23 (1):5-22", "ArticleIdList": ["27873462"]}, {"Citation": "N Engl J Med. 2013 Dec 5;369(23):2236-51", "ArticleIdList": ["24304053"]}, {"Citation": "FEBS Lett. 2015 Dec 21;589(24 Pt A):3702-13", "ArticleIdList": ["26526613"]}, {"Citation": "Annu Rev Cell Dev Biol. 2006;22:79-99", "ArticleIdList": ["16704336"]}, {"Citation": "Nat Genet. 2006 May;38(5):515-7", "ArticleIdList": ["16604074"]}, {"Citation": "Br J Pharmacol. 2011 Mar;162(5):1213-24", "ArticleIdList": ["21108628"]}, {"Citation": "Nat Rev Mol Cell Biol. 2014 Mar;15(3):150-1", "ArticleIdList": ["24518366"]}, {"Citation": "Int J Mol Sci. 2015 Sep 01;16(9):20704-30", "ArticleIdList": ["26340618"]}, {"Citation": "FASEB J. 2001 Jan;15(1):164-170", "ArticleIdList": ["11149904"]}, {"Citation": "Nat Rev Neurol. 2015 Jan;11(1):11-24", "ArticleIdList": ["25486875"]}, {"Citation": "J Cell Sci. 2004 Mar 1;117(Pt 7):1017-24", "ArticleIdList": ["14996933"]}, {"Citation": "Nat Med. 2016 Jan;22(1):54-63", "ArticleIdList": ["26618722"]}, {"Citation": "Behav Brain Res. 2012 May 1;230(2):309-16", "ArticleIdList": ["22178078"]}, {"Citation": "Curr Top Med Chem. 2015;15(5):458-83", "ArticleIdList": ["25620240"]}, {"Citation": "Neurobiol Dis. 2016 Jun;90:3-19", "ArticleIdList": ["26494254"]}, {"Citation": "J Neurosci. 2009 Oct 14;29(41):13019-29", "ArticleIdList": ["19828815"]}, {"Citation": "Mol Neurobiol. 2017 Jul;54(5):3783-3797", "ArticleIdList": ["27271125"]}, {"Citation": "Int J Mol Sci. 2016 Jun 08;17 (6):", "ArticleIdList": ["27338353"]}, {"Citation": "Mitochondrion. 2012 Jul;12 (4):428-37", "ArticleIdList": ["22609323"]}, {"Citation": "Lancet. 1989 Jun 3;1(8649):1269", "ArticleIdList": ["2566813"]}, {"Citation": "Transl Neurodegener. 2016 Jul 22;5:14", "ArticleIdList": ["27453777"]}, {"Citation": "Mov Disord. 2006 Oct;21(10):1595-606", "ArticleIdList": ["16830310"]}, {"Citation": "Curr Top Med Chem. 2016;16(8):858-66", "ArticleIdList": ["26311425"]}, {"Citation": "Neurotoxicology. 2015 Jan;46:101-16", "ArticleIdList": ["25514659"]}, {"Citation": "Neurotoxicology. 2016 Mar;53:302-313", "ArticleIdList": ["26141520"]}, {"Citation": "Hum Mol Genet. 2009 Oct 15;18(R2):R169-76", "ArticleIdList": ["19808793"]}, {"Citation": "Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2442-7", "ArticleIdList": ["17287338"]}]}], "History": [{"Year": "2017", "Month": "4", "Day": "27"}, {"Year": "2017", "Month": "9", "Day": "8"}, {"Year": "2017", "Month": "9", "Day": "6"}, {"Year": "2017", "Month": "10", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "12", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "10", "Day": "12", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29019159", "10.1007/s12640-017-9819-5", "10.1007/s12640-017-9819-5"]}}]}